We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Worldwide Regulatory Services for Medical Industry

By Biotechdaily staff writers
Posted on 20 Sep 2002
A consulting company provides comprehensive worldwide regulatory services to the medical industry.

The company, Regulatory Insight, Inc. (Littleton, CO, USA), says its clients benefit from its years of experience and established relationships with various regulatory bodies. The company promotes a collaborative approach to expediting all regulatory processes in an effort to save both time and expense.

The key services offered by the company include the following: US, Canadian, and European regulatory submissions; US agent representative for foreign companies; quality system development and review as per FDA's Code of Federal Regulations, the European Medical Devices Directive, and ISO-9000; clinical study design, monitoring, and analysis; and product recall/safety alert responses and corrective action plans.

The company also offers management or assistance with FDA or ISO inspections in preparation for import/export issues and market research to evaluate product design, market viability, and customer identification.




Related Links:
Regulatory Insight, Inc.

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
New
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test
Gold Member
Platelet Function Analyzer
PL-12

Latest BioResearch News

Genetic Study Links Inherited Blindness to Gene Tied to Rare Metabolic Disorder
20 Sep 2002  |   BioResearch

Population-Scale Proteomics Study Identifies New Genetic-Protein Links
20 Sep 2002  |   BioResearch

Circulating Tumor DNA Helps Identify Targets for Personalized Immunotherapy
20 Sep 2002  |   BioResearch